GENE & BIOLOGY
Human genetics establishes that reduced ASH1L function can cause autosomal-dominant syndromic neurodevelopmental disorder. Molecular studies reveal a large, regulated protein whose catalytic, reader, DNA-binding, nucleosome, and scaffold functions depend on the exact experimental context. This page distinguishes established gene-level evidence, direct mechanistic findings, and unresolved steps.
BIOLOGY DIRECTORY
Choose the evidence layer you need. Every reference system, mechanistic limit, primary study link, and unresolved step remains attached to its relevant route.
GENE & ALLELE ESSENTIALS
From gene-level certainty to an allele-specific molecular question.Start here for the established gene–disease relationship, reference systems, dosage evidence, and the measurements needed to move from a variant label to an allele-specific molecular consequence.
Open gene and allele essentials →PROTEIN & CHROMATIN MECHANISM
Keep the model, assay, and evidence limit attached.Protein architecture, nucleosome-context regulation, primary mechanistic studies, and chromatin logic—with model and assay limits attached.
Open protein and chromatin mechanism →DEVELOPMENTAL MODEL EVIDENCE
Use models to define questions—not to predict a person.Human neural-cell and mouse studies, limits on translation to people, and the unresolved steps needed to reach clinically useful mechanisms.
Open developmental models →CONTINUE THROUGH THE EVIDENCE
Move from molecular mechanism to variant positions, tissue experiments, research priorities, or published evidence.